tradingkey.logo
tradingkey.logo
検索

TELA Bio Inc

TELA
ウォッチリストに追加
0.706USD
-0.034-4.65%
終値 06/26, 16:00ET15分遅れの株価
27.91M時価総額
損失額直近12ヶ月PER

詳細情報 TELA Bio Inc 企業名

TELA Bio, Inc. is a commercial-stage medical technology company. The Company is focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy. Its first portfolio of products, the OviTex Reinforced Tissue Matrix (OviTex), addresses unmet needs in hernia repair and abdominal wall reconstruction. Its OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair. The Company's OviTex products include OviTex 1S, OviTex 2S, OviTex LPR, and OviTex IHR. Its second portfolio of products, the OviTex PRS Reinforced Tissue Matrix (OviTex PRS), addresses unmet needs in plastic and reconstructive surgery. OviTex PRS is indicated for use in implantation to reinforce soft tissue where weakness exists in patients requiring soft-tissue repair.

TELA Bio Incの企業情報

企業コードTELA
会社名TELA Bio Inc
上場日Nov 08, 2019
最高経営責任者「CEO」Koblish (Antony)
従業員数209
証券種類Ordinary Share
決算期末Nov 08
本社所在地1 Great Valley Parkway, Suite 24
都市MALVERN
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号19355
電話番号14843202930
ウェブサイトhttps://www.telabio.com/
企業コードTELA
上場日Nov 08, 2019
最高経営責任者「CEO」Koblish (Antony)

TELA Bio Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Antony Koblish
Mr. Antony Koblish
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
487.76K
+30.34%
Mr. Jeffrey (Jeff) Blizard
Mr. Jeffrey (Jeff) Blizard
President
President
198.75K
+43.27%
Mr. Paul Talmo
Mr. Paul Talmo
Chief Technology Officer
Chief Technology Officer
110.92K
+44.67%
Dr. Betty Jo Rocchio
Dr. Betty Jo Rocchio
Independent Director
Independent Director
23.60K
+49.47%
Ms. Federica F. O'Brien
Ms. Federica F. O'Brien
Independent Director
Independent Director
14.22K
+55.91%
Mr. Kurt Azarbarzin
Mr. Kurt Azarbarzin
Independent Director
Independent Director
14.22K
+55.91%
Mr. Douglas G. (Doug) Evans
Mr. Douglas G. (Doug) Evans
Independent Chairman of the Board
Independent Chairman of the Board
14.22K
+55.91%
Mr. Vince J. Burgess
Mr. Vince J. Burgess
Independent Director
Independent Director
--
--
Mr. Roberto E. Cuca, J.D.
Mr. Roberto E. Cuca, J.D.
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
--
--
Mr. Greg Firestone
Mr. Greg Firestone
Chief Commercial Officer
Chief Commercial Officer
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Antony Koblish
Mr. Antony Koblish
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
487.76K
+30.34%
Mr. Jeffrey (Jeff) Blizard
Mr. Jeffrey (Jeff) Blizard
President
President
198.75K
+43.27%
Mr. Paul Talmo
Mr. Paul Talmo
Chief Technology Officer
Chief Technology Officer
110.92K
+44.67%
Dr. Betty Jo Rocchio
Dr. Betty Jo Rocchio
Independent Director
Independent Director
23.60K
+49.47%
Ms. Federica F. O'Brien
Ms. Federica F. O'Brien
Independent Director
Independent Director
14.22K
+55.91%
Mr. Kurt Azarbarzin
Mr. Kurt Azarbarzin
Independent Director
Independent Director
14.22K
+55.91%

よくある質問

TELA Bio Incの上位5名の株主は誰ですか?

TELA Bio Incの上位5名の株主は以下のとおりです。Mr. Antony Koblish

TELA Bio Inc(TELA)の株式を保有している機関の数はいくつですか?

2026Q1時点で、TELA Bio Incの株式を保有している機関は163社あり、保有株式の総市場価値は約32.85Mで、全体の73.39%を占めています。2025Q4と比較して、機関の持ち株は-6147477.00増加しています。

TELA Bio Incの最大の収益源は何ですか?

2026Q1において、OviTex部門がTELA Bio Incにとって最大の収益を生み出しており、その金額は51.22Mで、全収益の63.81%を占めています。
KeyAI